Physician

Hussein Zaioor, MD

According to 2025 Medicare claims, Hussein Zaioor, MD (NPI: 1013919943) practices internal medicine in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Rock Island, IL. This provider's primary affiliated billing organization is ZAIOOR VALLEY INFECTIOUS DISEASE LLC (NPI: 1184198335; TIN: 813516568) and primary practice location at 61201-5351. Zaioor is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Zaioor's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 438 traditional Medicare patients, billed 2,455 HCPCS/CPT codes, and received $181,518 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 747 prescription claims across 167 beneficiaries totaling $232,573 in drug costs, led by Vemlidy (Tenofovir Alafenamide). 2019 DME data shows 260 claims. Open Payments data shows 4 records totaling $68. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $98,132 and ending at $181,518. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $32,104 to $232,573. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $60,077 to $4,657.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	277	1,728	$98,132
2016	394	2,354	$127,734
2017	703	3,789	$194,717
2018	608	3,167	$147,136
2019	711	3,473	$201,291
2020	913	4,006	$285,488
2021	657	3,260	$239,886
2022	506	2,877	$211,972
2023	432	2,607	$197,140
2024	438	2,455	$181,518

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	132	368	$32,104
2016	116	283	$71,569
2017	190	494	$83,983
2018	197	601	$71,483
2019	183	515	$168,292
2020	158	587	$158,897
2021	123	492	$125,292
2022	112	471	$105,778
2023	133	613	$190,915
2024	167	747	$232,573

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	141	324	$50,089
2016	169	243	$32,701
2017	246	323	$49,197
2018	231	309	$36,952
2019	195	260	$39,485
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	31	31	$119
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	375	474	$100
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	138	385	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	75	185	$66
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	343	1,370	$60

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Vemlidy	Tenofovir Alafenamide	12	360	$20,391
Ertapenem	Ertapenem Sodium	41	254	$17,764
Daptomycin	Daptomycin	50	285	$13,331
Vancomycin Hcl	Vancomycin Hcl	92	925	$10,482
Ceftriaxone	Ceftriaxone Sodium	76	339	$6,397

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$68	Insmed, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Hussein Zaioor, MD?

Tedicare shows public-source Medicare data for Hussein Zaioor, MD (NPI 1013919943), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hussein Zaioor, MD have ACO affiliation data?

Hussein Zaioor, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Hussein Zaioor, MD?

Hussein Zaioor, MD is linked to ZAIOOR VALLEY INFECTIOUS DISEASE LLC (billing NPI 1184198335) in the available physician profile data.

Does Hussein Zaioor, MD have Open Payments data?

Hussein Zaioor, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.